Nonheritable cellular variability accelerates the evolutionary processes of cancer.
Recent cancer studies emphasize that genetic and heritable epigenetic changes drive the evolutionary rate of cancer progression and drug resistance. We discuss the ways in which nonheritable aspects of cellular variability may significantly increase evolutionary rate. Nonheritable variability arises...
Main Authors: | Steven A Frank, Marsha Rich Rosner |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS Biology |
Online Access: | http://europepmc.org/articles/PMC3317895?pdf=render |
Similar Items
-
A Physiological Basis for Nonheritable Antibiotic Resistance
by: Mauricio H. Pontes, et al.
Published: (2020-06-01) -
The effects of individual nonheritable variation on fitness estimation and coexistence
by: M. Gabriela M. Gomes, et al.
Published: (2019-08-01) -
RKIP Suppresses Breast Cancer Metastasis to the Bone by Regulating Stroma-Associated Genes
by: Elena Bevilacqua, et al.
Published: (2012-01-01) -
Conceptualizing cancer drugs as classifiers.
by: Patrick Nathan Lawlor, et al.
Published: (2014-01-01) -
Targeting Raf Kinase Inhibitory Protein Regulation and Function
by: Ali Ekrem Yesilkanal, et al.
Published: (2018-09-01)